Presentation is loading. Please wait.

Presentation is loading. Please wait.

Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry) 

Similar presentations


Presentation on theme: "Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry) "— Presentation transcript:

1 Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)  Samip Vasaiwala, MD, MSc, Helen Vlachos, MSc, Faith Selzer, PhD, Oscar Marroquin, MD, Suresh Mulukutla, MD, J. Dawn Abbott, MD, David O. Williams, MD  American Journal of Cardiology  Volume 110, Issue 8, Pages (October 2012) DOI: /j.amjcard Copyright © 2012 Elsevier Inc. Terms and Conditions

2 Figure 1 Kaplan–Meier plots of 3-year cumulative incidence of (A) death, (B) myocardial infarction, and (C) coronary artery bypass grafting/repeat percutaneous coronary intervention in patients undergoing percutaneous coronary intervention for ostial lesions using bare-metal versus drug-eluting stents. American Journal of Cardiology  , DOI: ( /j.amjcard ) Copyright © 2012 Elsevier Inc. Terms and Conditions

3 Figure 2 Adjusted hazard rates/relative risk of patients undergoing percutaneous coronary intervention for ostial lesions. AHR = adjusted hazard ratio; CABG = coronary artery bypass grafting. American Journal of Cardiology  , DOI: ( /j.amjcard ) Copyright © 2012 Elsevier Inc. Terms and Conditions


Download ppt "Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry) "

Similar presentations


Ads by Google